In the past year, we’ve been pleased to see tremendous growth within the Patient Advisory Board Panel service. Sponsors, research centers, and contract research organizations are beginning to adopt CISCRP Patient Advisory Board Panels as they recognize the importance of incorporating the patient voice into the clinical research process.
“This recognition leads to enhancements of various aspects of proposed clinical research studies – including protocol design, informed consent, quality of life questionnaires, and patient recruitment materials. Ultimately, Patient Advisory Boards can lead to improving future study volunteer experiences,” says Annick Anderson, CISCRP Director of Research Services.
CISCRP has facilitated over ten Patient Advisory Boards over the past six months in the United States and abroad. As an independent unbiased third party, CISCRP brings a neutral and objective practice, a strong awareness of the clinical research process, and a plethora of experience working directly with patients and collaborating with patient advocacy organizations. Our goal is to ensure the patient voice is heard.
By providing a forum for patients to bring their thoughts out into the open, CISCRP can work with sponsors to modify different aspects of their clinical trial design to better resonate with the target population.
CISCRP’s Patient Advisory Board process works with sponsors to bring together six to eight patients of a particular therapeutic area and a target population for a focus-group style discussion about a variety of patient-facing materials such as study protocols, informed consent documents, and marketing materials. Panelists are prompted by CISCRP facilitators to “put on their research participant hats” and react to the materials as if they were participating in the specific study and receiving them for the first time from a member of the study staff.
Patient feedback offers unique insight into factors that may not otherwise be detected during the study design process. For example, a recent Panel reviewed a study visit schedule that required participants to visit the study site three times each month for a blood draw. The panel discussed how this might work for patients; would it be convenient with work schedules, or would such a design discourage participation?
The primary goal of these Patient Advisory Board Panels is to identify barriers of participation and think of ways to overcome these obstacles, making clinical research more accessible and comfortable for patients and participants.
For more information about this service, please contact Annick Anderson at email@example.com.